These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17402560)

  • 21. Combined anti-interleukin-2 receptor and low-dose cyclosporine therapy in experimental autoimmune uveoretinitis.
    Higuchi M; Diamantstein T; Osawa H; Caspi RR
    J Autoimmun; 1991 Feb; 4(1):113-24. PubMed ID: 1827711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10 has a protective role in experimental autoimmune uveoretinitis.
    Rizzo LV; Xu H; Chan CC; Wiggert B; Caspi RR
    Int Immunol; 1998 Jun; 10(6):807-14. PubMed ID: 9678762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
    Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
    Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
    Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
    Usui M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
    Ando K; Fujino Y; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of experimental autoimmune uveoretinitis (EAU) induced by interphotoreceptor retinoid-binding protein (IRBP) in the rat.
    Chan CC; Nussenblatt RB; Wiggert B; Redmond TM; Fujikawa LS; Chader GJ; Gery I
    Immunol Invest; 1987 Mar; 16(1):63-74. PubMed ID: 3497100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
    Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
    Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a new immunosuppressive agent, FK 506, on the efferent limb of the immune responses.
    Kawashima H; Mochizuki M
    Exp Eye Res; 1990 Nov; 51(5):565-72. PubMed ID: 1701148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.
    Bhuyan ZA; Asanoma M; Iwata A; Ishifune C; Maekawa Y; Shimada M; Yasutomo K
    PLoS One; 2014; 9(2):e89266. PubMed ID: 24586644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.